Match!
Philip A. Hines
European Medicines Agency
Health careSystematic reviewRegulatory scienceGrey literatureMedicine
3Publications
1H-index
2Citations
What is this?
Publications 4
Newest
After 3 years of co-design with stakeholders and EU regulatory partners, the European Medicines Agency’s Regulatory Science to 2025 strategy has been finalized. Here, we highlight the core recommendations that stakeholders deem most significant to advance evidence generation. After 3 years of co-design with stakeholders and EU regulatory partners, the European Medicines Agency’s Regulatory Science to 2025 strategy has been finalized. Here, we highlight the core recommendations that stakeholders ...
Source
#1Philip A. Hines (European Medicines Agency)H-Index: 1
#2Richard H. Guy (University of Bath)H-Index: 78
Last. Marisa Papaluca-Amati (European Medicines Agency)H-Index: 6
view all 5 authors...
: Regulatory science underpins the objective evaluation of medicinal products. It is therefore imperative that regulatory science and expertise remain at the cutting edge so that innovations of ever-increasing complexity are translated safely and swiftly into effective, high-quality therapies. We undertook a comprehensive examination of the evolution of science and technology impacting on medicinal product evaluation over the next 5-10 years and this horizon-scanning activity was complemented by...
1 CitationsSource
#1Philip A. Hines (European Medicines Agency)H-Index: 1
#2Richard H. GuyH-Index: 78
Last. Marisa Papaluca-Amati (European Medicines Agency)H-Index: 6
view all 4 authors...
It is increasingly important that regulatory agencies catalyse the translation of scientific and technological innovation into improved patient-centred health care. Here, we highlight the strategic goals of the European Medicines Agency to advance regulatory science and optimize the opportunities arising in areas such as cell and gene therapies, big data and artificial intelligence. It is increasingly important that regulatory agencies catalyse the translation of scientific and technological inn...
2 CitationsSource
#1Philip A. HinesH-Index: 1
Last. Marisa Papaluca-Amati (European Medicines Agency)H-Index: 6
view all 5 authors...
Objectives Society is confronted with the rapid emergence of innovation in science and technology. To manage this, horizon scanning is being adopted globally to identify, assess and prioritise innovations and trends at an early stage of their development. This enables decision-makers to be better informed and to prepare for change. The aim of this paper is to systematically identify and evaluate horizon scanning methodologies employed in the healthcare and biomedical fields. Methods A systematic...
Source
1